Mesenchymal Stem Cells Market Intelligence Report - Global Forecast to 2027

Mesenchymal Stem Cells Market Intelligence Report - Global Forecast to 2027

The Global Mesenchymal Stem Cells Market is projected to reach USD 5,847.88 million by 2027 from USD 2,731.51 million in 2021, at a CAGR 13.52% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Mesenchymal Stem Cells Market size was estimated at USD 1,113.77 million in 2021 and expected to reach USD 1,244.58 million in 2022, at a CAGR 12.99% to reach USD 2,317.98 million by 2027.
• The Asia-Pacific Mesenchymal Stem Cells Market size was estimated at USD 667.85 million in 2021 and expected to reach USD 780.85 million in 2022, at a CAGR 14.67% to reach USD 1,518.45 million by 2027.
• The Europe, Middle East & Africa Mesenchymal Stem Cells Market size was estimated at USD 949.88 million in 2021 and expected to reach USD 1,070.73 million in 2022, at a CAGR 13.31% to reach USD 2,011.44 million by 2027.

Market Segmentation & Coverage:

The report on mesenchymal stem cells identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the mesenchymal stem cells to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Allogeneic
• Autologous

Indication:

• Bone & Cartilage Repair
• Cancer
• Cardiovascular Disease
• GvHD
• Inflammatory & Immunological Disease
• Liver Diseases

Source of Isolation:

• Adipose Tissues
• Bone Marrow
• Cord Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Peripheral Blood

Application:

• Disease Modeling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Astellas Pharma Inc.
• Axol Biosciences Ltd.
• BrainStorm Cell Therapeutics Inc.
• Cell Applications, Inc.
• Celprogen, Inc.
• Cyagen Biosciences, Inc.
• Genlantis, Inc.
• Lonza Group AG
• Merck KGaA
• Mesoblast Limited
• Neuromics
• Pluristem Therapeutics Inc.
• PromoCell GmbH
• R&D Systems, Inc.
• ScienCell Research Laboratories, Inc.
• Smith & Nephew PLC
• Stemcell Technologies Inc.
• Stemedica Cell Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Vericel Corporation

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 2,731.51 million

Estimated Year Value: USD 3,096.17 million

Forecast Year Value: USD 5,847.88 million

CAGR (%): 13.52%.

Please Note: PDF & Excel + Online Access - 1 Year